Topics

Congenica Raises Additional £13.25M ($17.1M) to Reach Total of £23.3M ($30.1M) for Series B Funding Round

04:07 EDT 30 Apr 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Extension of Series B investment round, led by existing investor Parkwalk Advisors Digital China Health joins as new investor, building on existing strategic partnership Congenic...

Other Sources for this Article

For media enquiries, please contact:
Sue Charles / Tim Watson
Instinctif Partners
Telephone: +44-(0)20-7866-7863
Email: congenica@instinctif.com

NEXT ARTICLE

More From BioPortfolio on "Congenica Raises Additional £13.25M ($17.1M) to Reach Total of £23.3M ($30.1M) for Series B Funding Round"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...